Controlling the kinetics of interferon transgene expression for improved gene therapy
Authors:
- 20 September 2012
- journal article
- review article
- Published by Taylor & Francis in Journal of Drug Targeting
- Vol. 20 (9) , 764-769
Abstract
Interferon (IFN) gene based therapy has been studied for the treatment of many diseases such as viral infections, cancer and allergic diseases. Non-viral vectors, like plasmid DNA, are promising ways for delivering IFN genes, because of their low immunogenicity and toxicity compared with viral vectors. Potent therapeutic effects of IFN gene transfer will depend on the level and duration of transgene expression after in vivo administration. Therefore, controlling the kinetics of transgene expression of IFNs is a rational approach for improved gene therapy. The design and optimization of plasmid vectors, as well as their route/method of administration, is the key to obtaining high and persistent transgene expression. In this review, we aim to present experimental evidence about the relationships among the properties of plasmid vectors expressing IFNs, the kinetics of transgene expression, and therapeutic effects as well as safety issues.Keywords
This publication has 40 references indexed in Scilit:
- Constant and steady transgene expression of interferon‐γ by optimization of plasmid construct for safe and effective interferon‐γ gene therapyThe Journal of Gene Medicine, 2012
- Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liverJournal of Molecular Medicine, 2011
- Sustained Exogenous Expression of Therapeutic Levels of IFN-γ Ameliorates Atopic Dermatitis in NC/Nga Mice via Th1 PolarizationThe Journal of Immunology, 2010
- Redefining the role of interferon in the treatment of malignant diseasesEuropean Journal of Cancer, 2010
- Silencing of Episomal Transgene Expression in Liver by Plasmid Bacterial Backbone DNA Is Independent of CpG MethylationMolecular Therapy, 2008
- Gene therapy clinical trials worldwide to 2007—an updateThe Journal of Gene Medicine, 2007
- Regulated expression of the interferon-β gene in miceGene Therapy, 2007
- Gene therapy clinical trials worldwide 1989–2004—an overviewThe Journal of Gene Medicine, 2004
- Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivoGene Therapy, 2004
- Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivoMolecular Therapy, 2003